跳至主要内容
临床试验/EUCTR2017-003072-31-NL
EUCTR2017-003072-31-NL进行中(未招募)1 期

The effects of sex hormone administration on marrow and visceral adiposity - SHAMVA

VU University Medical Center0 个研究点目标入组 40 人开始时间: 2018年3月12日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Diagnosed with gender dysphoria according to DSM V (transmen or
  • transwomen)
  • - Age between 18 and 50 years
  • - Transmen need to be premenopausal
  • - Starting cross-sex hormone treatment
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Previous use of cross-sex hormones
  • Contraindications to MRI scanning as determined by the standard VUmc checklist (See F4. Checklist MRI)
  • Use of bone-modifying or adipose tissue-modifying drugs, current or in history
  • oBisphosphonates (alendronic acid, clodronic acid, ibandronic acid, pamidronic acid, risedronic acid, zoledronic acid, etidronate)
  • oEstrogen receptor modulators (raloxifene, bazedoxifene)
  • oCalcium regulating agents (denosumab, calcitonin, teriparatide, strontium ranelate, cinacalcet, etelcalcetine)
  • oCorticosteroids (
  • Bone or bone marrow diseases, current or in history
  • oMetabolic (osteroporosis, osteomalacia, dystosis, osteodystrophia, Pagets disease, osteogenesis imperfecta)
  • oMalignancy (primary, metastatic)
  • oInfectious (osteomyelitis, periostitis)
  • oMechanic (lumbal vertebral fracture)
  • Bone marrow diseases (leukemia, myelodysplastic syndrome, myeloproliferative disorders)
  • Platelet count <120*109/l
  • History of non-traumatic major bleeding
  • Known bleeding diathesis
  • Conditions which require antiplatelet therapy
  • Usage of antiplatelet therapy
  • Chronic usage of medication known to influence platelet function (e.g. DOAC’s, NSAIDs, warfarin)

研究者

发起方
VU University Medical Center

相似试验